Bendamustine

Overview

Bendamustine is a chemotherapy cancer medication that interferes with the growth and spread of cancer cells in the body. It is approved to treat B-cell non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL). It is also being studied in the treatment of other types of cancers, including multiple myeloma.

SparkCures ID 41
Developed By Teva Pharmaceuticals
Generic Name Bendamustine
Additional Names Treanda, SDX-105
Treatment Classifications

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.